|
PGM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21369999999776E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.69580000000714E-05 |
| Normal-vs-Stage2 |
6.449600E-04 |
| Normal-vs-Stage3 |
1.30450000002114E-06 |
| Normal-vs-Stage4 |
1.276580E-03 |
| Stage1-vs-Stage2 |
8.268200E-01 |
| Stage1-vs-Stage3 |
1.850150E-01 |
| Stage1-vs-Stage4 |
5.925400E-01 |
| Stage2-vs-Stage3 |
3.796400E-01 |
| Stage2-vs-Stage4 |
5.697200E-01 |
| Stage3-vs-Stage4 |
9.792800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.64339999959063E-07 |
| Normal-vs-AfricanAmerican |
4.522400E-02 |
| Normal-vs-Asian |
2.418300E-03 |
| Caucasian-vs-AfricanAmerican |
2.451400E-01 |
| Caucasian-vs-Asian |
6.535200E-01 |
| AfricanAmerican-vs-Asian |
1.421650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.92379999994519E-07 |
| Normal-vs-Female |
1.819420E-01 |
| Male-vs-Female |
6.181900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.145700E-02 |
| Normal-vs-Extreme_Weight |
6.37240005207929E-09 |
| Normal-vs-Obese |
3.025200E-04 |
| Normal-vs-Extreme_Obese |
1.734050E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.646400E-01 |
| Normal_Weight-vs-Obese |
9.784200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.840400E-01 |
| Extreme_Weight-vs-Obese |
5.366000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.123600E-01 |
| Obese-vs-Extreme_Obese |
8.716800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.566700E-04 |
| Normal-vs-Age(41-60Yrs) |
6.380200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.62656999999067E-05 |
| Normal-vs-Age(81-100Yrs) |
3.82399999998562E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.180400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.712000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.449700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.118000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.898150E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.976600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.00089999913678E-09 |
| Normal-VS-Type2 PRCC |
8.998800E-03 |
| Normal-VS-KIRP CIMP |
3.738500E-03 |
| Normal-VS-Unclassified PRCC |
2.264000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.360560E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.929800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.5627000000038E-05 |
| Type2 PRCC-VS-KIRP CIMP |
5.833200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.564250E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.105850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2744000000019E-06 |
| Normal-vs-N1 |
7.82559999999988E-05 |
| Normal-vs-N2 |
3.465800E-02 |
| N0-vs-N1 |
7.824200E-01 |
| N0-vs-N2 |
7.750600E-01 |
| N1-vs-N2 |
8.675600E-01 |
|
|
